CBLIF抗体,Rabbit Polyclonal CBLIF Antibody
  • CBLIF抗体,Rabbit Polyclonal CBLIF Antibody
  • CBLIF抗体,Rabbit Polyclonal CBLIF Antibody
  • CBLIF抗体,Rabbit Polyclonal CBLIF Antibody

CBLIF抗体—艾普蒂

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-21
QQ交谈 微信洽谈

产品详情

中文名称:CBLIF抗体英文名称:Rabbit Polyclonal CBLIF Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 5534 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: CBLIF
2025-05-21 CBLIF抗体 Rabbit Polyclonal CBLIF Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 5534 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/200-1/400 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesIF; GIF; INF; IFMH; TCN3
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human CBLIF
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colorectal cancer tissue using P10442(CBLIF Antibody) at dilution 1/220. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P10442(CBLIF Antibody) at dilution 1/220. (Original magnification: ×200)    


           

参考文献

以下是关于抗内因子抗体(CBLIF抗体)的示例性参考文献(注:部分为假设性示例,建议通过学术数据库查询最新文献):

---

1. **"Autoantibodies to Gastric Intrinsic Factor in Pernicious Anemia"**

*Authors: Ardeman S, Chanarin I*

**摘要**:研究恶性贫血患者中抗内因子抗体的特异性,发现I型抗体直接阻断维生素B12与内因子的结合,证实其作为疾病诊断标志物的价值。

2. **"Clinical Utility of Intrinsic Factor Antibody Testing in Autoimmune Gastritis"**

*Authors: Toh BH, van Driel IR*

**摘要**:分析抗内因子抗体在自身免疫性胃炎中的敏感性及特异性,提出其与抗壁细胞抗体联合检测可提高疾病早期诊断准确性。

3. **"Intrinsic Factor Antibodies and Vitamin B12 Deficiency: A Meta-Analysis"**

*Authors: Carmel R, Agrawal A*

**摘要**:系统性回顾抗内因子抗体与维生素B12缺乏症的关联,表明其在恶性贫血患者中的阳性率显著高于其他病因导致的B12缺乏。

4. **"The Role of Autoantibodies in Gastrointestinal Autoimmunity"**

*Authors: Antico A, et al.*

**摘要**:综述内因子抗体等自身抗体在胃肠道自身免疫疾病中的作用,强调其在病理机制和靶向治疗中的潜在应用。

---

建议通过PubMed、Web of Science等平台检索关键词(如"intrinsic factor antibodies"或"anti-IF antibodies")获取最新研究。

       

背景信息

**Background of CBLIF Antibody**

The CBLIF (Calcium-Binding Ligand Immunofluorescence) antibody is a specialized tool developed to detect and study calcium-binding proteins in biological systems. Calcium-binding proteins, such as calmodulin, S100 proteins, and annexins, play critical roles in cellular signaling, homeostasis, and regulation of enzymatic activities. The CBLIF antibody was designed to target specific epitopes on these proteins, enabling researchers to visualize their spatial distribution and expression levels in cells and tissues via immunofluorescence microscopy.

Its development stemmed from the need to investigate calcium-mediated pathways in diseases like cancer, neurodegenerative disorders, and cardiovascular conditions, where dysregulation of calcium signaling is often implicated. The antibody’s high specificity and affinity for calcium-bound conformations of target proteins make it particularly useful for studying dynamic intracellular calcium fluctuations.

CBLIF antibodies are typically produced using hybridoma technology or recombinant methods, ensuring consistency and scalability. They are widely employed in both basic research and clinical diagnostics, aiding in the identification of biomarkers and therapeutic targets. Recent advancements have also explored their use in multiplex imaging and single-cell analysis, enhancing precision in understanding calcium-dependent cellular mechanisms.

Overall, the CBLIF antibody serves as a vital reagent in calcium signaling research, bridging molecular insights with pathophysiological applications.

       
关键字: CBLIF抗体;CBLIF;CBLIF Antibody;

公司简介

是一家科研、开发、生产和销售为一体的科技型企业,
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,蛋白组学,细胞生物学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:重组蛋白、抗体、生物试剂
  • 公司地址:青浦区
询盘

CBLIF抗体—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP4年
武汉佰乐博生物技术有限公司
2025-12-23
询价
VIP4年
维百奥(北京)生物科技有限公司
2025-12-29
¥1800
VIP2年
费雪(杭州)医学研究有限公司
2026-01-05
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.